A new rabies vaccine strategy enhanced the speed and magnitude of the anti-rabies antibody responses and could improve the efficacy of currently used vaccines.
List view / Grid view
Filter the results
A new vaccine against the Staphylococcus aureus infection has proven effective in experiments with mice, with an 80 percent survival rate.
A study has demonstrated a novel vaccine design in mice which could be used to immunise patients against HIV.
It has been discovered that papillomaviruses induce immunity that protects patients, which could lead to a novel method for preventing skin cancer using a vaccine based on T cells.
Researchers have identified a set of three antibodies that they suggest could become the basis for a new antiviral treatment and inform the development of new influenza vaccines.
A new algorithm has been developed which personalises which cancer mutations are best targets for immunotherapy.
Molecules that are critical for T cells to travel to and populate the lungs have been identified which could strengthen vaccines against influenza.
Almost all animal subjects exposed to genital herpes were protected by the novel vaccine.
A study has shown that a mutated form of the Ebola virus protects macaque models against the disease, demonstrating an opportunity for a drug target.
Researchers have created a vaccine to treat and prevent streptococcal toxic shock syndrome which showed success in mice models.
Australian researchers have demonstrated the success of a novel TB vaccine in mice, which could provide another treatment option for the disease.
A molecular switch that impacts immune responses to viral infections has been identified which could lead to better strategies to develop vaccines.
Researchers have developed a new HIV vaccine which has shown success in monkeys in pre-clinical trial studies.
A promising vaccine that clears an HIV-like virus from monkeys is closer to clinical trial human testing.